Tilray Brands (TLRY) EBIT Margin (2017 - 2026)
Tilray Brands (TLRY) reported EBIT Margin of 12.76% for Q1 2026, up 39629.0% on a YoY basis from N/an in Q1 2025, and down 24.61% quarter-over-quarter from 10.24% in Q4 2025.
Tilray Brands (TLRY) EBIT Margin (2017 - 2026) Analysis & Trends
Tilray Brands has reported EBIT Margin for 10 years, with the latest figure at 12.76% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin rose 39629.0% year-over-year to 12.76%; the trailing twelve-month figure through Feb 2026 stood at 173.67% (down 7021.0% YoY), and the FY2025 full-year result was 277.93%, down 25579.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 12.76%, down from 10.24% in the prior quarter.
- The five-year high for EBIT Margin was 1.0% in Q3 2025, with the low at 828.86% in Q1 2023.
- Historically, EBIT Margin has averaged 144.03% across 5 years, with a median of 20.01% in 2024.
- Annual changes were most pronounced in 2023 — EBIT Margin plunged 81696 bps — and 2024, when it surged 78527 bps.
- Tilray Brands' EBIT Margin stood at 35.93% in 2022, then jumped by 40 bps to 21.55% in 2023, then climbed by 7 bps to 20.01% in 2024, then soared by 49 bps to 10.24% in 2025, then declined by 25 bps to 12.76% in 2026.
- The last three EBIT Margin figures came in at 12.76% (Q1 2026), 10.24% (Q4 2025), and 1.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Tilray Brands | - | - | 54.95 Mn | -12.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -12.76% |
| Nov 30, 2025 | -10.24% |
| Aug 31, 2025 | 1.00% |
| May 31, 2025 | -643.10% |
| Feb 28, 2025 | -409.05% |
| Nov 30, 2024 | -20.01% |
| Aug 31, 2024 | -18.28% |
| May 31, 2024 | -7.19% |
| Feb 29, 2024 | -43.59% |
| Nov 30, 2023 | -21.55% |
| Aug 31, 2023 | -19.42% |
| May 31, 2023 | -48.85% |
| Feb 28, 2023 | -828.86% |
| Nov 30, 2022 | -35.93% |
| Aug 31, 2022 | -13.82% |
| May 31, 2022 | -304.86% |
| Feb 28, 2022 | -11.90% |
| Nov 30, 2021 | -35.79% |
| Aug 31, 2021 | -41.29% |
| May 31, 2021 | -9.79% |